首页>
外国专利>
Neuro-protective combination for treating cerebral ischaemia - contains a 5-HT1A receptor agonist and 5-HT2 receptor antagonist
Neuro-protective combination for treating cerebral ischaemia - contains a 5-HT1A receptor agonist and 5-HT2 receptor antagonist
展开▼
机译:用于治疗脑缺血的神经保护组合-包含5-HT1A受体激动剂和5-HT2受体拮抗剂
展开▼
页面导航
摘要
著录项
相似文献
摘要
A combination prepn. consists of (A) an active ingredient with a serotonin agonistic effect, which has a bonding strength on 5-HT 1A receptors smaller than 10000 nmol/l. amd (B) an active ingredient with a serotonin antagonistic effect which has a bonding strength on 5-HT2 receptors smaller than 1000 nmol/l. (A) is Ipsapiron, Gepiron or Buspiron and (B) is ketanserin. Other suitable components B are Pipamperon, Spiperon, Ritanserin or Pirenperin. Wt. ratio A:B is 1:0.01-100. USE/ADVANTAGE - The combination can be used in neuroprotective pharmaceuticals esp. in the treatment of cerebral ischaemia. The neuroprotective effect of (B) is increased synergistically by (A). Suitable daily doses of the combination are 0.01-100 (esp. 1-50) mg/kg
展开▼